ClinicalTrials.govpublic full text
Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy
prostate cancer, radiotherapy, chromogranin a, neuroendocrine differentiation, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 863876
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.